Related Experiment Video
Updated: Aug 15, 2026

11:52
Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Nanoparticle-Like Scavenger Mediated by NIR/pH Stimulation for MRSA-Associated Infections
Xiangjun Chen1, Sai Zhang1, Yating Liu1
1School of Pharmacy, Shandong Medical and Pharmaceutical University, Yantai, People's Republic of China.
Small (Weinheim an Der Bergstrasse, Germany)
|August 14, 2026
Summary
This study introduces novel nanoparticles that combine copper sulfide, a nitric oxide donor, and red blood cell membranes to combat antibiotic-resistant bacteria. This innovative approach effectively eliminates MRSA and its biofilms, offering a new treatment strategy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to its resistance to multiple antibiotics.
- MRSA infections are characterized by numerous virulence factors and complex pathogenic pathways, complicating treatment strategies.
Purpose of the Study:
- To develop a novel nanotherapeutic system for effective elimination of MRSA and its biofilms.
- To utilize hollow copper sulfide nanoparticles (CuS NPs) as carriers for S-nitrosoglycine (GSNO) and camouflage them with red blood cell membranes (RBCMs).
Main Methods:
- Fabrication of CuS-GSNO@RBCM NPs for targeted delivery and enhanced therapeutic effects.
- Utilizing near-infrared laser irradiation to induce a photothermal effect from CuS NPs, generating reactive oxygen species (ROS).
- Exploiting the acidic microenvironment to release copper ions, triggering GSNO to produce nitric oxide (NO) and reactive nitrogen species (RNS).
Main Results:
- The combined ROS and RNS generation disrupted MRSA's redox homeostasis by consuming glutathione.
- Copper ions induced bacterial death, creating a multi-bactericidal network.
- Red blood cell membranes (RBCMs) mitigated lung cell injury by neutralizing MRSA-secreted proteins.
- In vitro and in vivo studies confirmed the system's efficacy against MRSA.
Conclusions:
- The CuS-GSNO@RBCM NP system presents an innovative nanotherapeutic strategy for treating drug-resistant bacterial infections.
- This approach offers a multi-pronged attack against MRSA, involving photothermal therapy, ROS/RNS generation, and copper ion toxicity.
- The RBCM camouflage enhances safety by reducing host cell damage.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbial Corrosion
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

